December 01, 2022
A New Jersey federal judge has upheld four patents owned by pharmaceutical company Bausch Health in its patent suit against a generic drugmaker over psoriasis treatments Duobrii and Bryhali, finding Thursday that the asserted claims are not invalid as obvious or indefinite.